Hikma Pharmaceuticals PLC (HKMPY)
USD 48.77
(0.0%)
USD 48.77
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.87 Billion | 2.51 Billion | 2.55 Billion | 2.34 Billion | 2.2 Billion | 2.07 Billion |
| Cost of Revenue | 1.48 Billion | 1.27 Billion | 1.25 Billion | 1.14 Billion | 1.05 Billion | 1.02 Billion |
| Gross Profit | 1.39 Billion | 1.23 Billion | 1.3 Billion | 1.2 Billion | 1.14 Billion | 1.05 Billion |
| Operating Expenses | 1.04 Billion | 756 Million | 742 Million | 687 Million | 655 Million | 690 Million |
| Selling, General and Administrative Expenses | 632 Million | 509 Million | 488 Million | 464 Million | 494 Million | 470 Million |
| Research and Development Expenses | 149 Million | 144 Million | 143 Million | 137 Million | 150 Million | 147 Million |
| Other Expenses | 259 Million | 103 Million | 111 Million | 86 Million | 11 Million | 55 Million |
| Cost and Expenses | 2.5 Billion | 2.03 Billion | 1.99 Billion | 1.82 Billion | 1.71 Billion | 1.71 Billion |
| Operating Income | 367 Million | 507 Million | 582 Million | 579 Million | 493 Million | 371 Million |
| Interest Expense | 87 Million | 77 Million | 69 Million | 69 Million | 67 Million | 80 Million |
| Income Tax Expense | 89 Million | 42 Million | 124 Million | 128 Million | 4 Million | 8 Million |
| Earnings before Tax | 281 Million | 233 Million | 544 Million | 558 Million | 491 Million | 293 Million |
| Net Income | 190 Million | 188 Million | 421 Million | 431 Million | 486 Million | 282 Million |
| Earnings Per Share Basic | 1.72 | 1.68 | 3.65 | 3.65 | 4.02 | 2.34 |
| Earnings Per Share Diluted | 1.71 | 1.67 | 3.61 | 3.62 | 4.00 | 2.33 |
| Weighted Average Shares Outstanding | 110.43 Million | 112 Million | 115.5 Million | 118 Million | 121 Million | 120.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 111.18 Million | 112.5 Million | 116.5 Million | 119 Million | 121.5 Million | 121 Million |
| Gross Margin | 0.48 | 0.49 | 0.51 | 0.51 | 0.52 | 0.51 |
| EBIT Margin | 0.19 | 0.28 | 0.29 | 0.28 | 0.30 | 0.23 |
| Profit Margin | 0.07 | 0.07 | 0.16 | 0.18 | 0.22 | 0.14 |
| EBITDA | 559 Million | 493 Million | 766 Million | 747 Million | 660 Million | 456 Million |
| Earnings Before Tax Margin | 0.13 | 0.20 | 0.23 | 0.25 | 0.22 | 0.18 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 1.56 Billion | 1.43 Billion | 2.87 Billion | 1.42 Billion | 2.51 Billion | 1.36 Billion |
| Cost of Revenue | 813 Million | 813.48 Million | 1.48 Billion | 737 Million | 1.27 Billion | 745.8 Million |
| Gross Profit | 756 Million | 623 Million | 1.39 Billion | 690 Million | 1.23 Billion | 622.03 Million |
| Operating Expenses | 405 Million | 498.01 Million | 785 Million | 342 Million | 756 Million | 358.74 Million |
| Selling, General and Administrative Expenses | 280 Million | 414.67 Million | - | 260 Million | - | 280.07 Million |
| Research and Development Expenses | 61 Million | 84.32 Million | - | 64 Million | - | 78.67 Million |
| Other Expenses | 64 Million | 992.04 Thousand | -17 Million | -18 Million | 103 Million | - |
| Cost and Expenses | 1.21 Billion | 1.31 Billion | 2.27 Billion | 1.07 Billion | 2.03 Billion | 1.1 Billion |
| Operating Income | 351 Million | 124.99 Million | 367 Million | 348 Million | 507 Million | 263.28 Million |
| Interest Expense | 44 Million | 42.65 Million | 90 Million | 44 Million | 77 Million | 46.15 Million |
| Income Tax Expense | 59 Million | 17.85 Million | 89 Million | 71 Million | 42 Million | 1.04 Million |
| Earnings before Tax | 288 Million | 78.37 Million | 281 Million | 202 Million | 233 Million | 18.88 Million |
| Net Income | 226 Million | 58.53 Million | 190 Million | 131 Million | 188 Million | 15.73 Million |
| Earnings Per Share Basic | 1.02 | 0.53 | - | 1.19 | - | 0.14 |
| Earnings Per Share Diluted | 1.01 | 0.52 | - | 1.18 | - | 0.14 |
| Weighted Average Shares Outstanding | 223.76 Million | 110.27 Million | 110.43 Million | 110.5 Million | 112 Million | 110.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 223.76 Million | 111.59 Million | 111.18 Million | 111 Million | 112.5 Million | 110.11 Million |
| Gross Margin | 0.48 | 0.43 | 0.48 | 0.48 | 0.49 | 0.45 |
| EBIT Margin | 0.32 | 0.15 | - | 0.31 | - | 0.27 |
| Profit Margin | 0.14 | 0.04 | 0.07 | 0.09 | 0.07 | 0.01 |
| EBITDA | 499 Million | 219.24 Million | - | 444 Million | - | 365.03 Million |
| Earnings Before Tax Margin | 0.22 | 0.09 | 0.13 | 0.24 | 0.20 | 0.19 |
FBCPF
0Y5E
VLID3
300110
DPUM
GGPS3